Preemption Policy Demands More Meetings With, Documentation From FDA

FDA's assertion of the preemption of physician labeling will likely lead to more discussions between sponsors and the agency regarding the presentation of risk information in labeling, according to Coleen Klasmeier, a former special assistant to the FDA's chief counsel